Diclofenac Sodium
Product Images NDC 10544-923

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 10544-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (Label Diclofenac Sodium Dr Tabs 50mg Bpi(10544 923 14) Actavis(0228 2550 11) Rev1)

This is a description of a medication named Diclofenac Sodium Delayed-Release Tablets, USP with 50 mg and 14 tablets, which requires a prescription. The tablets are packaged by Blenheim Pharma and have an expiry date. The tablets must be kept in a controlled room temperature below 35°C, in a moisture-free, light-resistant container, and out of children's reach. The dosage information is not available. There are multiple lots of this medication with different NDCs, LCNs, and MFGs, and their respective expiry dates and lot numbers.*

FDA Label Image

78e77986-figure-01 (Diclofenac Sodium Dr Tablets Usp 1 (2))

FDA Label Image

78e77986-figure-02 (Diclofenac Sodium Dr Tablets Usp 2 (2))

FDA Label Image

78e77986-figure-03 (Diclofenac Sodium Dr Tablets Usp 3 (2))

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.